Mitsubishi Chemical Denies Sale Reports of Mitsubishi Tanabe Pharma

MT Newswires Live

2024/09/10

Mitsubishi Chemical (TYO:4188) has denied recent reports by Nikkei suggesting it is negotiating the sale of Mitsubishi Tanabe Pharma Corporation, according to a Monday filing on the Tokyo Stock Exchange.

The company clarified that it has not announced any such sale and emphasized that no such transaction is currently underway.

Mitsubishi Chemical is actively reviewing its business portfolio, including its pharmaceutical segment, and is considering various strategic options, including divestitures.

Price (JPY): $911.60, Change: $+11, Percent Change: +1.17%

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2466717623"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2466717623\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2466717623?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-10 11:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2466717623","market":"sh","top_or_hot":-1,"title":"Mitsubishi Chemical Denies Sale Reports of Mitsubishi Tanabe Pharma","media":"MT Newswires Live","content":"<html><body><p>Mitsubishi Chemical Denies Sale Reports of Mitsubishi Tanabe Pharma</p><p> Mitsubishi Chemical (TYO:4188) has denied recent reports by Nikkei suggesting it is negotiating the sale of Mitsubishi Tanabe Pharma Corporation, according to a Monday filing on the Tokyo Stock Exchange.</p><p>The company clarified that it has not announced any such sale and emphasized that no such transaction is currently underway.</p><p>Mitsubishi Chemical is actively reviewing its business portfolio, including its pharmaceutical segment, and is considering various strategic options, including divestitures.</p><p>Price (JPY): $911.60, Change: $+11, Percent Change: +1.17%</p></body></html>","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mitsubishi Chemical Denies Sale Reports of Mitsubishi Tanabe Pharma</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMitsubishi Chemical Denies Sale Reports of Mitsubishi Tanabe Pharma\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MT Newswires Live</strong><span class=\"h-time small\">2024-09-10 11:44</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><p>Mitsubishi Chemical Denies Sale Reports of Mitsubishi Tanabe Pharma</p><p> Mitsubishi Chemical (TYO:4188) has denied recent reports by Nikkei suggesting it is negotiating the sale of Mitsubishi Tanabe Pharma Corporation, according to a Monday filing on the Tokyo Stock Exchange.</p><p>The company clarified that it has not announced any such sale and emphasized that no such transaction is currently underway.</p><p>Mitsubishi Chemical is actively reviewing its business portfolio, including its pharmaceutical segment, and is considering various strategic options, including divestitures.</p><p>Price (JPY): $911.60, Change: $+11, Percent Change: +1.17%</p></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://www.mtnewswires.com/\">MT Newswires Live</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_JMI","symbol_name":"OSE小日經","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2466717623","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466717623","pubTimestamp":1725939878,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"Mitsubishi Chemical Denies Sale Reports of Mitsubishi Tanabe Pharma Mitsubishi Chemical (TYO:4188) h","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TYO":"3倍做空7-10年期国债ETF-Direxion"},"translate_title":"三菱化学否认出售三菱田边制药的报道","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JMImain":1,"TYO":1,"JNImain":1,"NKmain":1,"NIYmain":1},"content_text":"Mitsubishi Chemical Denies Sale Reports of Mitsubishi Tanabe Pharma Mitsubishi Chemical (TYO:4188) has denied recent reports by Nikkei suggesting it is negotiating the sale of Mitsubishi Tanabe Pharma Corporation, according to a Monday filing on the Tokyo Stock Exchange.The company clarified that it has not announced any such sale and emphasized that no such transaction is currently underway.Mitsubishi Chemical is actively reviewing its business portfolio, including its pharmaceutical segment, and is considering various strategic options, including divestitures.Price (JPY): $911.60, Change: $+11, Percent Change: +1.17%","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}